Page 4 of 16
This Amendment is being filed by CBG Holdings LLC, a Delaware limited liability company (“CBG”), and Constellation Brands, Inc., a Delaware corporation (“Constellation”) pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
This Amendment amends the Schedule 13D filed on July 17, 2018 by Greenstar Canada Investment Limited Partnership (“Greenstar LP”), Greenstar Canada Investment Corporation, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation (the “Initial Schedule 13D”), as the Initial Schedule 13D was amended by Amendment No. 1 filed on August 16, 2018 (the “First Amendment” and, together with the Initial Schedule 13D, the “Schedule 13D”), by Greenstar LP, Greenstar Canada Investment Corporation, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, CBG, Constellation International Holdings Limited and Constellation (collectively, the “Reporting Persons”).
Item 1. Security and Issuer.
Item 1 of the Schedule 13D is hereby amended and restated in its entirety as follows:
The title and class of equity securities to which this Amendment No. 2 to Schedule 13D (this “Amendment”) relates is the Common Shares, no par value (the “Common Shares”), of Canopy Growth Corporation, a company organized and existing under the laws of Canada (the “Issuer” or “Canopy”). The principal executive offices of the Issuer are located at 1 Hershey Drive, Smith Falls, Ontario Canada, K7A 0A8.
Item 2. Identity and Background.
Item 2 of the Schedule 13D is hereby revised and supplemented with the following:
(a) – (c) The principal office address or business address of Greenstar LP and of Greenstar Canada Investment Corporation is 150 King Street West, Suite 200, Toronto, Ontario M5H 1J9.
Current information concerning the identity and background of each executive officer and director of CBG, Greenstar Canada Investment Corporation, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation is set forth on Annex A (collectively, the “Covered Persons”), attached hereto and incorporated herein by reference.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Schedule 13D is hereby revised and supplemented with the following:
The sources of the Purchase Price (as defined in Item 4 below) paid by Constellation and CBG for the Shares and the CBG Warrants consisted of the following:
| • | | the net proceeds from the sale of Constellation’s $650.0 million aggregate principal amount of Senior Floating Rate Notes due 2021, $500 million aggregate principal amount of 4.400% Senior Notes due 2025, $500.0 million aggregate principal amount of 4.650% Senior Notes due 2028, and $500.0 million aggregate principal amount of 5.250% Senior Notes due 2048 (collectively, the “Notes”); |
| • | | $1,500.0 million in term loans consisting of a $500.0 million three-year term facility (the “Three-Year Term Facility”) and a $1,000.0 million five-year term facility (the “Five-Year Term Facility”) borrowed by Constellation; and |
| • | | $240.0 million in proceeds of borrowings under Constellation’s commercial paper program. |
The Notes were issued on October 29, 2018 under the indenture, dated as of April 17, 2012, as amended (the “Indenture”), and supplemental indentures thereto (the “Supplemental Indentures”), among Constellation, Manufacturers and Traders Trust Company, as trustee, and the guarantors named therein. On September 14, 2018, Constellation, Bank of America, N.A., as administrative agent and certain other lenders named therein entered into a Term Loan Credit Agreement (the “Term Credit Agreement”). The Three-Year Term Facility and the Five-Year Term Facility are provided under the Term Credit Agreement.
The above descriptions of the Indenture, Supplemental Indentures and the Term Credit Agreement are qualified in their entirety by the terms of the Indenture, Supplemental Indentures and the Term Credit Agreement which are filed as Exhibits 99.4 through 99.9 to this Amendment.